Bhaven Sampat
Bhaven Sampat
Department of Health Policy and Management, Columbia University
Verified email at - Homepage
Cited by
Cited by
The growth of patenting and licensing by US universities: an assessment of the effects of the Bayh–Dole act of 1980
DC Mowery, RR Nelson, BN Sampat, AA Ziedonis
Research policy 30 (1), 99-119, 2001
Ivory tower and industrial innovation: University-industry technology transfer before and after the Bayh-Dole Act
DC Mowery, RR Nelson, BN Sampat, AA Ziedonis
Stanford University Press, 2015
Universities in national innovation systems
DC Mowery
Georgia Institute of Technology, 2005
Making sense of institutions as a factor shaping economic performance
RR Nelson, BN Sampat
Journal of economic behavior & organization 44 (1), 31-54, 2001
The Bayh-Dole Act of 1980 and university–industry technology transfer: a model for other OECD governments?
DC Mowery, BN Sampat
The Journal of Technology Transfer 30 (1), 115-127, 2004
How do university inventions get into practice?
J Colyvas, M Crow, A Gelijns, R Mazzoleni, RR Nelson, N Rosenberg, ...
Management science 48 (1), 61-72, 2002
Patenting and US academic research in the 20th century: The world before and after Bayh-Dole
BN Sampat
Research Policy 35 (6), 772-789, 2006
Applicant and examiner citations in US patents: An overview and analysis
J Alcácer, M Gittelman, B Sampat
Research Policy 38 (2), 415-427, 2009
Changes in university patent quality after the Bayh–Dole act: a re-examination
BN Sampat, DC Mowery, AA Ziedonis
International Journal of Industrial Organization 21 (9), 1371-1390, 2003
Learning to patent: Institutional experience, learning, and the characteristics of US university patents after the Bayh-Dole Act, 1981-1992
DC Mowery, BN Sampat, AA Ziedonis
Management Science 48 (1), 73-89, 2002
How do patents affect follow-on innovation? Evidence from the human genome
B Sampat, HL Williams
American Economic Review 109 (1), 203-36, 2019
University patents and patent policy debates in the USA, 1925–1980
DC Mowery, BN Sampat
Industrial and corporate change 10 (3), 781-814, 2001
Evergreening, patent challenges, and effective market life in pharmaceuticals
CS Hemphill, BN Sampat
Journal of health economics 31 (2), 327-339, 2012
Public R&D investments and private-sector patenting: evidence from NIH funding rules
P Azoulay, JS Graff Zivin, D Li, BN Sampat
The Review of economic studies 86 (1), 117-152, 2019
Examiner characteristics and patent office outcomes
MA Lemley, B Sampat
Review of economics and statistics 94 (3), 817-827, 2012
Is the patent office a rubber stamp
MA Lemley, B Sampat
Emory LJ 58, 181, 2008
Patenting and licensing university inventions: lessons from the history of the research corporation
DC Mowery, BN Sampat
Industrial and Corporate Change 10 (2), 317-355, 2001
Do applicant patent citations matter?
CA Cotropia, MA Lemley, B Sampat
Research Policy 42 (4), 844-854, 2013
When do generics challenge drug patents?
CS Hemphill, BN Sampat
Journal of Empirical Legal Studies 8 (4), 613-649, 2011
What are the respective roles of the public and private sectors in pharmaceutical innovation?
BN Sampat, FR Lichtenberg
Health affairs 30 (2), 332-339, 2011
The system can't perform the operation now. Try again later.
Articles 1–20